Company intelligence / Profile preview
URSAPHARM
Saarbrücken, Saarland, Germany
- Ownership
- Private
- Employees
- ~950
- Development stage
- Other
01
Overview
URSAPHARM is a commercial-stage, mid-sized German pharmaceutical manufacturer and market leader in ophthalmology and particularly dry eye/eye lubrication, with widely marketed product families such as HYLO EYE CARE and hysan, and a long-established, patented preservative‑free delivery platform (COMOD system) used in eye and nasal preparations that are sold in over 80 countries.
- Therapeutic areas
- ImmunologyOtherCardiovascularMetabolic DisordersOphthalmology
- Modalities
- Small moleculeBiologicProteinDevice
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →03
Partnerships
Scope Eyecare: long-term collaboration in the European dry eye sector and expanded partnership for launch of OPTASE HYLO dry eye products in the USA from 2021.Multiple international distribution partners in over 74–80 countries (not individually named).
Beyond the preview
Go deeper on URSAPHARM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on URSAPHARM.